152 related articles for article (PubMed ID: 33682495)
1. Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis.
Zhou C; Yang Q
J Int Med Res; 2021 Mar; 49(3):300060521993312. PubMed ID: 33682495
[TBL] [Abstract][Full Text] [Related]
2. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
He W; Tang B; Yang D; Li Y; Song W; Cheang T; Chen X; Li Y; Chen L; Zhan W; Li W; He Y
World J Surg Oncol; 2013 Jul; 11():161. PubMed ID: 23866030
[TBL] [Abstract][Full Text] [Related]
3. High Mobility Group Box 1 (HMGB1) expression in gastric adenocarcinomas.
Suren D; Arda Gokay A; Sayiner A
J BUON; 2018; 23(2):422-427. PubMed ID: 29745087
[TBL] [Abstract][Full Text] [Related]
4. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Significance of Neuropilin 1 Expression in Gastric Cancer: A Meta-Analysis.
Cao H; Li Y; Huang L; Bai B; Xu Z
Dis Markers; 2020; 2020():4763492. PubMed ID: 33014187
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of snail protein expression in gastric cancer: a meta-analysis.
Chen X; Li J; Hu L; Yang W; Lu L; Jin H; Wei Z; Yang JY; Arabnia HR; Liu JS; Yang MQ; Deng Y
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):22. PubMed ID: 27461247
[TBL] [Abstract][Full Text] [Related]
7. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
9. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.
Kishi S; Nishiguchi Y; Honoki K; Mori S; Fujiwara-Tani R; Sasaki T; Fujii K; Kawahara I; Goto K; Nakashima C; Kido A; Tanaka Y; Luo Y; Kuniyasu H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068442
[TBL] [Abstract][Full Text] [Related]
10. The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.
Zhang L; Han J; Wu H; Liang X; Zhang J; Li J; Xie L; Xie Y; Sheng X; Yu J
PLoS One; 2014; 9(10):e110626. PubMed ID: 25356587
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer.
Fang J; Ge X; Xu W; Xie J; Qin Z; Shi L; Yin W; Bian M; Wang H
J Cell Physiol; 2020 Apr; 235(4):3438-3446. PubMed ID: 31621076
[TBL] [Abstract][Full Text] [Related]
12. Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus.
Zhou Y; Liu SX; Zhou YN; Wang J; Ji R
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1339-1350. PubMed ID: 33629304
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis.
Tan G; Liu B
Sci Rep; 2023 Jun; 13(1):8937. PubMed ID: 37264076
[TBL] [Abstract][Full Text] [Related]
14. Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.
Chung HW; Lee SG; Kim H; Hong DJ; Chung JB; Stroncek D; Lim JB
J Transl Med; 2009 May; 7():38. PubMed ID: 19476625
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
16. Lack of relationship between PROX1 expression and clinicopathological parameters and prognosis in gastric cancer patients: a meta-analysis and TCGA analysis.
Jia Z; Wang Y; Gao J; Zu G
BMC Gastroenterol; 2022 Mar; 22(1):142. PubMed ID: 35346069
[TBL] [Abstract][Full Text] [Related]
17. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
[TBL] [Abstract][Full Text] [Related]
18. The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review.
Zhang X; Yu J; Li M; Zhu H; Sun X; Kong L
Onco Targets Ther; 2016; 9():4901-11. PubMed ID: 27540303
[TBL] [Abstract][Full Text] [Related]
19. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
20. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
